Thank you. I will take that question.
We are working with provinces and territories as well as Canada's Drug Agency, which is the health technology assessor, on ways in which we can accelerate our processes. Health Canada is responsible for reviewing the safety and efficacy of a drug, but there are steps being taken to accelerate some of the health technology reviews, sometimes in parallel with the work that Health Canada is also doing.
We're also working, for example, with international partners. Oncology drugs are a good example of that in respect of an initiative called project Orbis. The initiative is to help accelerate the approval and review of those drugs so that provinces can make faster decisions to add those to their formularies, as the Province of Ontario has committed to do just recently.
